Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?
Pagedocc1
1 other identifier
interventional
2,700
1 country
1
Brief Summary
The propose of this study is to assess the effect of general practitioner's involvement on first patients' solicitation in screening for colorectal cancer by testing for faecal occult blood (FOBT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable colorectal-cancer
Started Sep 2010
Shorter than P25 for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 18, 2011
CompletedFirst Posted
Study publicly available on registry
January 19, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedJanuary 19, 2011
September 1, 2010
7 months
January 18, 2011
January 18, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion of Fecal Occult Blod Test
Increased number of patients who completed the test for faecal occult blood following the first solicitation with the letter co-signed by general practitioner, compared with the conventional solicition(including replies exclusions).
7 months
Secondary Outcomes (3)
Measure the impact of co-signing on deadline for completion of the test after the mailing.
7 months
Compare the proportion of uninterpretable tests.
7 months
Compare the rate of completion of colonoscopy after a positive test (information received by ADECA in the follow-up), according to the specifications.
7 months
Study Arms (2)
Control
NO INTERVENTIONCo-signed Letter
EXPERIMENTALInterventions
Patients receive a personalized letter co-signed by their general practitioner and the medical coordinator of ADECA.
Patients receive classical letter signed by the coordinator doctor of ADECA
Eligibility Criteria
You may qualify if:
- Aged : 50 to 74 years.
- Not having ever been invited to participate in colorectal screening.
You may not qualify if:
- Patients who have a Fecal Occult Blood Test for less than 2 years or a colonoscopy within the past 5 years or excluded for medical reasons (according to information known from ADECA).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Paris 5 - Rene Descarteslead
- Adeca 75collaborator
- Société de Formation Thérapeutique du Généralistecollaborator
- Hotel Dieu Hospitalcollaborator
Study Sites (1)
Université Paris Descartes
Paris, Île-de-France Region, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 18, 2011
First Posted
January 19, 2011
Study Start
September 1, 2010
Primary Completion
April 1, 2011
Study Completion
April 1, 2011
Last Updated
January 19, 2011
Record last verified: 2010-09